Aniela Montserrat Silva Nolasco | Pharmaceutical Chemistry | Excellence in Research Award

Published on 15/05/202615/05/2026 by Top Pharmaceutical

Excellence in Research Award

Universidad de Castilla-La Mancha, Spain

Aniela Montserrat Silva Nolasco
Affiliation	Universidad de Castilla-La Mancha
Country	Spain
Scopus ID	57221107566
Documents	21
Citations	23
h-index	2
Subject Area	Pharmaceutical Chemistry
Event	International Top Pharmaceutical Awards

Aniela Montserrat Silva Nolasco is a pharmaceutical science researcher associated with Universidad de Castilla-La Mancha, Spain. Her academic profile demonstrates research engagement in molecular pharmacology, pharmaceutical chemistry, cancer biology, and bioactive therapeutic compounds. Published studies associated with her scholarly work examine anticancer properties of argentatins, immunomodulatory activity, and translational therapeutic applications in oncology-related biomedical sciences.[1] Her research contributions are indexed through recognized academic databases including Scopus and ORCID, supporting international visibility and scientific dissemination within pharmaceutical and biomedical research communities.[2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This article summarizes the academic contributions and pharmaceutical research activities of Aniela Montserrat Silva Nolasco. The profile reflects scholarly involvement in cancer biology, molecular pharmacology, pharmaceutical chemistry, and translational therapeutic research involving argentatin compounds and related bioactive agents.[3] Indexed publications, DOI-linked research outputs, and collaborative scientific studies contribute to the researcher’s academic visibility within pharmaceutical and biomedical sciences.[4]

Keywords

Pharmaceutical Chemistry, Molecular Pharmacology, Anticancer Research, Argentatins, Cancer Biology, Translational Medicine, Immunomodulation, Biomedical Sciences, Oncology Research, Therapeutic Compounds.

Introduction

Pharmaceutical research associated with molecular therapeutics and cancer-related biomedical investigations continues to contribute substantially to contemporary translational medicine. Current scientific developments increasingly emphasize naturally derived compounds with potential therapeutic applications against tumor progression and immune dysregulation.[5] Research contributions associated with Aniela Montserrat Silva Nolasco demonstrate participation in this evolving pharmaceutical research landscape through investigations involving argentatins and cellular pharmacological mechanisms.[6]

Research Profile

The academic profile of Aniela Montserrat Silva Nolasco includes affiliations with Universidad de Castilla-La Mancha and previous research and educational activities associated with pharmaceutical and molecular sciences. Her scholarly background includes pharmaceutical biology, cellular pharmacology, and laboratory-based biomedical investigations relevant to therapeutic development and oncology-focused pharmaceutical sciences.[2]

The Scopus profile linked to the researcher identifies indexed publication activity, citation tracking, and collaborative research participation within pharmaceutical and biomedical disciplines. These indicators support measurable academic visibility and ongoing scholarly communication across internationally indexed scientific platforms.[1]

Research Contributions

Research contributions associated with Aniela Montserrat Silva Nolasco include investigations on argentatin compounds and their biological activity in cancer-related cellular environments. Published studies report antimigratory and antiangiogenic effects alongside analyses of long-term resistance induction associated with argentatin A and argentatin B.[3]

Additional scientific contributions address immunomodulatory activity isolated from guayule-derived compounds and synergistic therapeutic interactions involving 5-fluorouracil in colorectal cancer cell models. These studies contribute to broader translational pharmaceutical research exploring molecular therapeutic strategies in oncology-related biomedical sciences.[4]

Publications

The publication profile associated with Aniela Montserrat Silva Nolasco includes peer-reviewed research outputs indexed through recognized scientific databases. DOI-linked publications contribute to scholarly accessibility, research transparency, and international academic dissemination within pharmaceutical chemistry and molecular biomedical sciences.[3][4]

DOI-linked publications facilitate long-term accessibility and citation reliability within digital academic infrastructures. The use of persistent identifiers further supports research transparency, discoverability, and scholarly preservation across multidisciplinary scientific environments.[3]

Research Impact

Research impact is commonly evaluated using publication visibility, citation performance, indexed dissemination, and scholarly engagement across scientific communities. The researcher’s profile demonstrates documented participation in peer-reviewed pharmaceutical and biomedical research activities through Scopus-indexed publications and DOI-associated scholarly outputs.[1]

The available citation indicators and publication metrics support measurable academic relevance within specialized pharmaceutical chemistry and translational biomedical research domains. Continued scientific dissemination and collaborative publication activity may further strengthen long-term academic visibility and research influence.[2]

Award Suitability

The research activities and scholarly outputs associated with Aniela Montserrat Silva Nolasco align with the objectives of the International Top Pharmaceutical Awards through contributions to pharmaceutical chemistry, cancer-related therapeutic investigations, and molecular biomedical sciences.[6] The profile reflects participation in interdisciplinary scientific studies relevant to pharmaceutical innovation and translational therapeutic development.[3]

Conclusion

Aniela Montserrat Silva Nolasco has contributed to pharmaceutical and biomedical research through studies involving anticancer compounds, immunomodulatory activity, and molecular therapeutic investigations. Her academic profile demonstrates scholarly engagement within pharmaceutical chemistry and translational medicine, supported by indexed publications, collaborative research contributions, and DOI-linked scientific dissemination.[5]

External Links

References

Elsevier. (n.d.). Scopus author details: Aniela Montserrat Silva Nolasco, Author ID 57221107566. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57221107566
ORCID. (2026). Aniela M. Silva-Nolasco ORCID profile, affiliations, and academic activities.https://orcid.org/0000-0002-2134-7551
Silva-Nolasco, A. M., Galvez, B. G., de la Cruz-Morcillo, M. A., & Carmona, M. (2026). Differential anti-cancer effects of argentatin A and B: antimigratory, antiangiogenic, and long-term resistance induction. Industrial Crops and Products.https://doi.org/10.1016/j.indcrop.2026.123255
Silva-Nolasco, A. M., Singh, N., de la Cruz-Morcillo, M. A., García-Martínez, M. M., Zalacain, A., Gálvez, B. G., & Carmona, M. (2024). Immunomodulatory activity of argentatins A and B isolated from guayule. PLOS ONE.https://doi.org/10.1371/journal.pone.0304713
Sánchez‐Olivares, P., Silva‐Nolasco, A. M., de la Cruz‐Morcillo, M. A., García‐Martínez, M. M., Pinedo‐Serrano, A., Carmona, M., & Galán‐Moya, E. M. (2024). Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models. Journal of Cellular and Molecular Medicine.https://doi.org/10.1111/jcmm.70294

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Published on 17/06/202517/06/2025 by Top Pharmaceutical

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Prof. Dr. Shobha Singh, Hygia Institute of Pharmaceutical Education and Research, Lucknow, India

Prof. Dr. Shobha Singh is a distinguished academic and researcher in pharmaceutical sciences, currently serving at Hygia Institute of Pharmaceutical Sciences, Lucknow 🏫. With a Ph.D. from AcSIR–CSIR-NBRI (2022) and a specialization in Pharmaceutical Chemistry 💊, she brings over a decade of teaching and 6 years of research experience. Her expertise spans synthetic organic chemistry, phytochemistry, and heterocyclic compound synthesis 🔬. A member of IPGA and the Society of Ethnopharmacology 🌱, she has guided numerous M. Pharm. theses and contributed to international conferences. Her passion and innovation continue to drive excellence in drug research and development.

Publication Profile

Orcid

Education

Prof. Dr. Shobha Singh has pursued a strong academic path in the field of pharmaceutical sciences 📚. She earned her Ph.D. from AcSIR, CSIR-NBRI, Lucknow, with a CGPA of 7.42 🧪. She completed her M. Pharm. in Pharmaceutical Chemistry from Uttar Pradesh Technical University in 2008 with an impressive 80.30% 🧬. Her B. Pharm. was accomplished at Northern India Engineering College in 2006 with 65.83% 📖. Prior to that, she excelled in her Intermediate (1999) and High School (1997) from U.P. Board with 70% marks in both 🎯—showcasing a consistent academic record 📈.

Experience

Prof. Dr. Shobha Singh brings over a decade of valuable teaching experience in pharmaceutical sciences 🎓. She began her academic journey as a Lecturer at the Rameshwaram Institute of Technology and Management, Lucknow, from July 23, 2008, to April 2011 🏫. She then served as an Assistant Professor at Sherwood College of Pharmacy, Barabanki, from August 16, 2011, to January 16, 2014 🧪. Currently, she continues to educate and guide M. Pharm. students specializing in Pharmaceutical Chemistry 💊—inspiring future researchers and professionals with her deep subject expertise and mentorship 🌟.

Awards

Prof. Dr. Shobha Singh has marked her journey with notable academic and professional achievements 🏆. She holds a prestigious lifetime membership with the Indian Pharmacy Graduates’ Association (I.P.G.A.) 🧬 and is also a proud member of the Society of Ethnopharmacology 🌿, reflecting her commitment to advancing traditional and modern pharmaceutical sciences. Her academic excellence is further highlighted by qualifying the GATE examination twice, in 2006 and 2009 🎓, and the GPAT examination in 2013 📘. These accolades not only signify her academic rigor but also her dedication to continuous professional growth and research excellence 📈.

Research Focus

Prof. Dr. Shobha Singh’s research focus lies at the intersection of phytochemistry, pharmaceutical chemistry, and natural product pharmacology 🌿🧪. She specializes in the phytochemical investigation and biological evaluation of medicinal plants such as Ajuga parviflora, Sesbania sesban, and Sesbania grandiflora 🌸. Her work spans the synthesis of novel heterocyclic compounds, antioxidant activity, and in silico and in vivo pharmacological screening, particularly for anticonvulsant and anticancer properties 🧬💥. She integrates traditional knowledge with modern techniques like molecular docking, enhancing drug discovery from natural sources 🔍🌍. Her research supports innovation in plant-based drug development.

Publication Top Notes

Phytochemical and pharmacological evaluation of Ajuga parviflora Benth

Synthesis and in silico and in vivo anticonvulsant activities of substituted 2-phenyl indole derivatives

Phytochemical investigation and in-vitro antioxidant activity of Sesbania sesban and Sesbania grandiflora seeds

Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Published on 21/05/202521/05/2025 by Top Pharmaceutical

Rajashree Patnaik | Pharmaceutical Chemistry | Best Researcher Award

Dr. Rajashree Patnaik, MBRU, United Arab Emirates

Dr. Rajashree Patnaik is a dedicated biotechnology researcher specializing in inflammation, cancer, and stem cell biology. She earned her Ph.D. in Biotechnology in 2018 from Siksha ‘O’ Anusandhan University, India, with a focus on environmental toxicology using human cord blood stem cells. Currently a Postdoctoral Researcher at MBRU, UAE 🇦🇪, she investigates bioceuticals, statins, and venom-derived peptides in disease models. A Gold Medalist 🎖️ in both BSc and MSc, she has published extensively in international journals and received multiple accolades, including the QUWA Research Award 🏆 and Best Poster Award at an international stem cell conference.

Publication Profile

Google Scholar

Education

Dr. Rajashree Patnaik 🎓 earned her Ph.D. in Biotechnology from Siksha ‘O’ Anusandhan University, Bhubaneswar, in February 2018. Her thesis focused on monitoring the toxicity of environmental chemicals using cultured stem cells from human cord blood 🧪🧫. She is skilled in FACS, cell culture, ELISA, Western Blot, RT-PCR, fluorescence microscopy, and karyotyping 🔬. Dr. Patnaik also holds an MSc in Biotechnology (2009–2011) from Berhampur University, where she studied the impact of climate change on plant productivity 🌱. She completed six months of training at the Institute of Life Sciences, JNU, and has a BSc in Zoology (Hons.).

Awards

Dr. Rajashree Patnaik 🌟 has been honored with the Excellence in Research Award for the Best Research Proposal at the 5th Forum for Women in Research – QUWA, UOS 👩‍🔬. She also received the Best Poster Award at the International Conference on Stem Cells, Cancer & Biotechnology held in Goa, India, in 2016 🧬🏆. Dr. Patnaik is a two-time Gold Medalist, having earned top honors in both her MSc in Biotechnology (2011) and BSc in Zoology (Hons.) from Berhampur University, India 🎖️🎓. Her dedication to science and innovation continues to earn her recognition and inspire excellence.

Research Focus

Dr. Rajashree Patnaik primarily focuses on toxicology, stem cell research, natural product pharmacology, and anti-inflammatory interventions using both traditional and modern scientific methods. Her research spans in vitro cytotoxicity, phytochemical analysis, chemotherapeutic screening, and regenerative medicine, particularly investigating natural compounds like curcumin, oleocanthal, and herbal extracts against microbial pathogens, cancer, and inflammatory diseases. She is also active in exploring NOACs, environmental toxins, and PAR-2-mediated pathways in disease contexts like osteoarthritis and cancer. Her interdisciplinary work integrates cell biology, pharmacognosy, and biomedical applications.

Publication Top Notes

In vitro antibacterial activity, gas chromatography–mass spectrometry analysis of Woodfordia fruticosa Kurz. leaf extract and host toxicity testing with in vitro cultured …

Human dental pulp stem cells differentiation to neural cells, osteocytes and adipocytes-An in vitro study

Reconnoitering the therapeutic role of curcumin in disease prevention and treatment: Lessons learnt and future directions

An in vitro study of Ocimum sanctum as a chemotherapeutic agent on oral cancer cell-line

In vitro combinational efficacy of ceftriaxone and leaf extract of Combretum albidum G. Don against multidrug-resistant Pseudomonas aeruginosa and host-toxicity testing with …

Evaluation of geno-toxicity of methyl parathion and chlorpyrifos to human liver carcinoma cell line (HepG2)

Comparative study on toxicity of methylmercury chloride and methylmercury hydroxide to the human neuroblastoma cell line SH-SY5Y

Beyond anticoagulation: a Comprehensive Review of Non-vitamin K oral anticoagulants (NOACs) in inflammation and protease-activated receptor signaling

Cellular and Nuclear Toxicity of HgCl₂ to In Vitro Grown Lymphocytes from Human Umbilical Cord Blood

Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof …

Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Published on 20/05/202520/05/2025 by Top Pharmaceutical

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Mrs. Akhlesh Kumari, IFTM University Moradabad, India

Mrs. Akhlesh Kumari 📚👩‍🎓 is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry 📊. With an M. Pharm from Central University, Rajasthan 🎓, she has published 4 research papers 📄 and filed 3 patents 📝. Her research focuses on Pharmaceutical Chemistry 🔬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field 🌟. With a citation index of 13 📈, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher 🔍.

Publication Profile

Google Scholar

Education

Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences 📚. With 8 years of teaching experience 📝, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India 🎓, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India 🏫. Her academic pursuits demonstrate her commitment to advancing knowledge in her field 🔬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.

Professional Memberships

Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits 📚. Although she doesn’t hold any specific professional memberships 🤝, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences 🌐. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field 🔬.

Research Focus

Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.

Publication Top Notes

Ruthenium‐catalyzed oxidative annulation of anilines using benzothiazole as a removable directing group

Synthesis, computational studies of new thymol derived chalcones and their benzotriazoles as antimicrobial agents

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Published on 22/04/202522/04/2025 by Top Pharmaceutical

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Dr. Shah Nawaz Khan, Shanghai Jiao Tong University, China

Dr. Shah Nawaz Khan, Ph.D. is a distinguished pharmaceutical chemist at Shanghai Jiao Tong University, specializing in organic synthesis, medicinal chemistry, and chemical biology. With a Ph.D. in Pharmaceutical Chemistry, his research spans photocatalytic decarboxylation, transition metal catalysis, and drug discovery. He has led projects on nucleoside antibiotics, shikonin derivatives, and natural product synthesis, contributing to cutting-edge solutions in biomedical innovation. Dr. Khan has an impressive publication record in high-impact journals and actively collaborates on international research initiatives.

Publication Profile

Orcid

Education

Dr. Shah Nawaz Khan 🎓 is a highly accomplished scholar in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the School of Pharmacy, Shanghai Jiao Tong University 🇨🇳 (2016–2022). Prior to that, he completed his M.Phil. in Organic Synthesis at the University of Malakand 🇵🇰 (2012–2014), following his Doctor of Pharmacy degree from Gomal University (2004–2009). His academic journey began with an F.Sc. in Pre-Medical (2002–2004) and Matriculation in Science (2001–2002), both from Oxford Education Academy 🏫 in KPK, Pakistan. His strong educational foundation reflects a deep commitment to pharmaceutical research and academic excellence 🔬📚.

Experience

Dr. Shah Nawaz Khan 🔬 has extensive research experience in medicinal and pharmaceutical chemistry. Since Nov 2022, he has been a Postdoctoral Fellow at the School of Chemistry and Chemical Engineering, SJTU 🇨🇳, working on projects like the total synthesis of natural products (GR24), Ullmann coupling, and nucleoside synthesis. His Ph.D. (2016–2022) at SJTU focused on photocatalytic decarboxylative C-O, C-C, and C-N functionalization 🌟, using photoredox and transition metal catalysis. During his M.Phil. (2012–2014) at UOM 🇵🇰, he explored pharmacological activities and synthesized amide derivatives through one-pot reactions. His work bridges synthetic innovation and biological significance 🧪💊.

Awards

Dr. Shah Nawaz Khan 🏅 has been honored with several awards and certificates recognizing his academic, professional, and extracurricular contributions. He received certificates of appreciation for workshops and seminars on faculty development, allied health sciences, and nursing (2020–2022) 🎓. He earned a Personal Protective Equipment Training certificate during the COVID-19 pandemic 🦺 and was awarded the prestigious CSC Type A Scholarship 🇨🇳 in 2016. Earlier, he participated in the “GSK Gold Challenge” (2010), organized national-level declamation contests (2008), and alumni events (2007) 🗣️. Additionally, he holds over 10 sports certificates 🏆, reflecting a well-rounded and active educational journey.

Research Focus

Dr. Shah Nawaz Khan’s research centers on pharmaceutical chemistry and medicinal compound development, particularly emphasizing anticancer, antimicrobial, and antiviral agents. His work explores naphthoquinone derivatives, cyclopeptides, and photocatalytic processes, aiming to discover novel bioactive compounds for drug discovery and skin therapies. Additionally, he contributes to the understanding of molecular mechanisms of action and synthetic methodologies in organic chemistry. His research spans diverse fields including pharmacology, biotechnology, and chemical engineering, reflecting a multidisciplinary approach toward innovative therapeutic solutions. 🌱💊🧬 His cutting-edge investigations significantly impact disease treatment, drug design, and biomedical science.

Publication Top Notes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening

Synthesis and germination activity study of novel strigolactam/strigolactone analogues

Decarboxylative oxidation-enabled consecutive C-C bond cleavage

Decarboxylative oxidation enabled consecutive C-C bond cleavage

Synthesis, characterization and antinociceptive activities of Novel 2-(2,4-dichlorophenyl)-4H-chromen-4-one

Pharmacological Activities and One Pot Two Step Synthesis of Novel (E)-N-(1-methyl-4-oxoimidazolidin-2-ylidene)benzamide

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Published on 28/02/202528/02/2025 by Top Pharmaceutical

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr Salih PAŞA, Afyon Kocatepe University, Turkey

Assoc. Prof. Dr. Salih PAŞA is an esteemed inorganic chemist specializing in pharmaceutical chemistry, anticancer research, and catalytic investigations. He earned his BSc (2007), MSc (2010), and PhD (2014) in Inorganic Chemistry. With extensive expertise in boron compounds, biodegradable polymers, and spectroscopy techniques, he has significantly contributed to Schiff base ligand coordination chemistry and Suzuki coupling reactions. Currently, he serves at Afyon Kocatepe University, Turkey. His pioneering work on boron-based cancer therapeutics and water purification underscores his impactful research.

Publication Profile

google scholar

Education

Assoc. Prof. Dr. Salih Paşa 🎓 has built a strong academic foundation in chemistry, specializing in inorganic chemistry. He earned his Bachelor of Science (BSc) degree in Chemistry (2002-2007) 🧪, followed by a Master of Science (MSc) in Inorganic Chemistry (2007-2010) ⚗️. His passion for research and scientific exploration led him to pursue a PhD in Inorganic Chemistry (2010-2014) 🔬. Through years of dedication, he has contributed significantly to the field, advancing knowledge in chemical sciences. His academic journey reflects a commitment to excellence, making valuable contributions to research and education in inorganic chemistry. 📚✨

Research Interest

Assoc. Prof. Dr. Salih Paşa 🔬 focuses his research on the coordination chemistry of polydentate ligands, particularly thio Schiff bases and their transition metal complexes. His work explores their analytical applications, synthetic utility, and biological activity 🧪. He is especially interested in palladium complexes of (N,O,S) and (N,O,P) type ligands, known for their catalytic role in Suzuki coupling reactions ⚗️. Additionally, he investigates boronic acids, unique boron-based compounds that act as Lewis acids, forming reversible covalent bonds with sugars, amino acids, and other Lewis base donors. His studies contribute significantly to advancing inorganic and organometallic chemistry. 🌟

Instrumental Expertise

Assoc. Prof. Dr. Salih Paşa 🎓 possesses extensive expertise in advanced analytical instrumentation, crucial for modern chemical research. He is highly skilled in techniques such as LC-MS/MS, NMR (¹³C & ¹H), XRD, SEM, FTIR, UV-Vis, AAS, GC, and thermal analysis 🔬⚗️. His proficiency in single-crystal X-ray diffraction studies allows for precise molecular structure determination, enhancing the understanding of complex chemical compounds 🧪. With a strong command of these instrumental techniques, he contributes significantly to inorganic and materials chemistry, facilitating groundbreaking research in coordination chemistry, catalysis, and boron-based compounds. His expertise ensures high precision in chemical analysis.

Future Potential

Assoc. Prof. Dr. Salih Paşa 🌱🔬 is actively exploring innovative research in sustainable chemistry and materials science. His recent work focuses on developing biodegradable polymer materials from waste potato starch, contributing to green chemistry and environmental sustainability 🌍♻️. Additionally, his research on the polymerization of Schiff base ligands opens new possibilities in advanced materials, with potential applications in catalysis, drug delivery, and nanotechnology ⚗️. Through his dedication to eco-friendly solutions and cutting-edge polymer research, he aims to revolutionize materials science, creating sustainable alternatives that benefit both industry and the environment. His work paves the way for a greener future. 🌟

Scientific Recognition

Assoc. Prof. Dr. Salih Paşa 📚🔬 has earned significant scientific recognition through multiple publications in high-impact SCI journals, including Chinese Chemical Letters, Inorganica Chimica Acta, Polyhedron, Applied Catalysis A, Applied Organometallic Chemistry, and Tetrahedron: Asymmetry 🏆. His collaborations with international researchers, particularly from Kazakh-British Technical University, highlight his global academic influence 🌍🤝. His contributions to catalysis, drug discovery, and polymer chemistry reinforce the importance of his research, driving advancements in these fields. Through his dedication and impactful studies, he continues to shape the future of inorganic and organometallic chemistry. ⚗️✨

Research Focus

Assoc. Prof. Dr. Salih Paşa’s research primarily focuses on green chemistry 🌱, nanotechnology 🧪, and materials science 🏗️. His work includes the green synthesis of nanoparticles ⚛️, biodegradable materials for eco-friendly applications 🌍, and catalysis in organic synthesis 🔬. He has contributed significantly to biodegradable food packaging 🍽️, anticancer drug discovery 🏥, and advanced polymer materials 🏭. His studies on Schiff bases 🧬, metal complexes ⚗️, and biocompatible materials 🔄 highlight his expertise in designing sustainable and functional materials with industrial and biomedical applications. His work aligns with pharmaceutical chemistry 💊, material engineering 🏢, and green nanotechnology 🌿.

Publication Top Notes

Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells

The fabrication of bilayer polylactic acid films from cross-linked starch as eco-friendly biodegradable materials: synthesis, characterization, mechanical and physical properties

Silane doped biodegradable starch-PLA bilayer films for food packaging applications: Mechanical, thermal, barrier and biodegradability properties

Synthesis, characterization and catalytic behavior in the Suzuki reaction of Schiff base and its complexes and the optical properties of nickel complex used in the fabrication …

Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol

Synthesis, characterization, electrochemical behaviors and applications in the Suzuki–Miyaura cross-coupling reactions of N2S2O2 thio Schiff base ligand and its Cu (II), Co …

Physicochemical properties for food packaging and toxicity behaviors against healthy cells of environmentally friendly biocompatible starch/citric acid/polyvinyl alcohol …

The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities

Structural investigation of raw clinoptilolite over the Pb2+ adsorption process from phosphoric acid

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Published on 29/01/202529/01/2025 by Top Pharmaceutical

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Assoc. Prof. Dr Amedea B. Seabra, Universidade Federal do ABC, Brazil

Assoc. Prof. Dr. Amedea B. Seabra is a renowned researcher in Chemistry at Universidade Federal do ABC (UFABC), Brazil. With a Ph.D. from UNICAMP, she specializes in biomaterials, nitric oxide release, and drug delivery systems. Her research includes developing novel materials for medical applications, such as nitric oxide-releasing hydrogels and vascular prostheses. Dr. Seabra has contributed significantly to projects related to wound healing and cardiovascular health. She has received numerous accolades, including recognition in global scientific databases and awards for her work on antimicrobial silver nanoparticles. 🌟🔬💉📚🌍

Publication Profile

Google Scholar

Academic Excellence

Assoc. Prof. Dr. Amedea B. Seabra holds a PhD in Chemistry from Universidade Estadual de Campinas (UNICAMP) and completed postdoctoral research at Concordia University and UNICAMP. Specializing in the controlled release of drugs, biomaterials, and nitric oxide chemistry, she has made significant contributions to both basic and applied sciences. Dr. Seabra’s work bridges the gap between research and practical applications, particularly in advancing drug delivery systems and exploring innovative biomaterials. Her research continues to have a profound impact on the development of therapeutic strategies for various medical challenges. 🧪💊🔬🌍

Professional Engagement

Assoc. Prof. Dr. Amedea B. Seabra is a distinguished academic with a wealth of experience in the field of biotechnology. Currently, she serves as the Vice Coordinator at the UFABC Graduate Program in Biotechnology and works as a collaborative researcher at the University of Edinburgh. Dr. Seabra has actively contributed to various international projects, including the prestigious Newton Advanced Fellowship. Her dedication to advancing research and fostering global collaborations highlights her commitment to scientific progress. 🌍🔬👩‍🔬💡

Awards and Recognition

Assoc. Prof. Dr. Amedea has made remarkable contributions to the scientific community, earning widespread recognition for her work. She was included in the prestigious Top 100,000 Scientists by C-Score and named among the most influential scientists globally in 2023 by Elsevier and Stanford University. Her exceptional achievements reflect her dedication and impact in her field. 🌍🔬📚🌟 Her ongoing research continues to inspire and drive advancements, solidifying her place as a leading figure in the scientific world. 👩‍🔬✨

Research Focus

Assoc. Prof. Dr. Amedea B. Seabra’s research focuses on nanotechnology, particularly the toxicology and antimicrobial properties of nanoparticles. Her studies investigate the synthesis, characterization, and biological effects of metal nanoparticles, such as silver and copper, including their cytotoxicity, genotoxicity, and environmental hazards. She has explored the potential of biogenically synthesized nanoparticles and their application in medicine, such as antimicrobial activity and toxicity in model organisms. Her work extends to the use of cellulose nanocrystals in medicine and addresses the risks posed by metal oxide nanoparticles. Overall, her research contributes to the safe application of nanomaterials. 🧬🧪⚛️